ATHENA-MONO (GOG-3020/ENGOT-ov45): A randomized, double-blind, phase 3 trial evaluating rucaparib monotherapy versus placebo as maintenance treatment following response to first-line platinum-based chemotherapy in ovarian cancer

Monk B. J., Parkinson C., Lim M. C., O'Malley D. M., Oaknin A., Wilson M. K., ...Daha Fazla

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), ELECTR NETWORK, 3 - 07 Haziran 2022 identifier

  • Yayın Türü: Bildiri / Özet Bildiri
  • Basıldığı Ülke: ELECTR NETWORK
  • İstanbul Üniversitesi Adresli: Evet